Assessment of SS-A SS-B in parotid saliva of patients with Sjögren's syndrome

Ann Rose Hammi, Ibtisam H. Al-Hashimi, Martha E. Nunn, Michele Zipp

Research output: Contribution to journalArticle

26 Citations (Scopus)

Abstract

BACKGROUND: The purpose of this study was to compare the sensitivity of parotid saliva to that of serum in detecting anti-SSA/Ro and anti-SSB/La autoantibodies in patients with Sjögren's syndrome. METHODS: Forty patients and 20 controls participated in the study; all patients met the 1993 European Community criteria for the diagnosis of Sjögren's syndrome. Healthy controls were age- and sex-matched individuals with no signs or symptoms of Sjögren's syndrome. Serum and saliva samples were evaluated using AffiniTech SSA/ Ro and SSB/La antibodies kits (AffiniTech, Ltd. Bentonville, AR, USA). The results were also compared with serological status of SS-A and SS-B as reported by an independent clinical laboratory. RESULTS: Serum was significantly more sensitive than saliva in detecting SSA/Ro and SSB/La antibodies (P = 0.001). There was high agreement between the results with the AffiniTech kits and the independent laboratory (kappa = 0.80; P <0.001). However, there was poor agreement between saliva and serum results (kappa = 0.174; P = 0.168). CONCLUSIONS: The overall results appear to support that serum analysis is effective method for evaluating the presence of SS-A and SS-B autoantibodies.

Original languageEnglish
Pages (from-to)198-203
Number of pages6
JournalJournal of Oral Pathology and Medicine
Volume34
Issue number4
DOIs
StatePublished - Apr 2005
Externally publishedYes

Fingerprint

Saliva
Serum
Autoantibodies
Antibodies
European Union
Signs and Symptoms

All Science Journal Classification (ASJC) codes

  • Cancer Research
  • Pathology and Forensic Medicine
  • Dentistry(all)

Cite this

Assessment of SS-A SS-B in parotid saliva of patients with Sjögren's syndrome. / Hammi, Ann Rose; Al-Hashimi, Ibtisam H.; Nunn, Martha E.; Zipp, Michele.

In: Journal of Oral Pathology and Medicine, Vol. 34, No. 4, 04.2005, p. 198-203.

Research output: Contribution to journalArticle

Hammi, Ann Rose ; Al-Hashimi, Ibtisam H. ; Nunn, Martha E. ; Zipp, Michele. / Assessment of SS-A SS-B in parotid saliva of patients with Sjögren's syndrome. In: Journal of Oral Pathology and Medicine. 2005 ; Vol. 34, No. 4. pp. 198-203.
@article{e555c19c2fba449789f43c67f1fc7985,
title = "Assessment of SS-A SS-B in parotid saliva of patients with Sj{\"o}gren's syndrome",
abstract = "BACKGROUND: The purpose of this study was to compare the sensitivity of parotid saliva to that of serum in detecting anti-SSA/Ro and anti-SSB/La autoantibodies in patients with Sj{\"o}gren's syndrome. METHODS: Forty patients and 20 controls participated in the study; all patients met the 1993 European Community criteria for the diagnosis of Sj{\"o}gren's syndrome. Healthy controls were age- and sex-matched individuals with no signs or symptoms of Sj{\"o}gren's syndrome. Serum and saliva samples were evaluated using AffiniTech SSA/ Ro and SSB/La antibodies kits (AffiniTech, Ltd. Bentonville, AR, USA). The results were also compared with serological status of SS-A and SS-B as reported by an independent clinical laboratory. RESULTS: Serum was significantly more sensitive than saliva in detecting SSA/Ro and SSB/La antibodies (P = 0.001). There was high agreement between the results with the AffiniTech kits and the independent laboratory (kappa = 0.80; P <0.001). However, there was poor agreement between saliva and serum results (kappa = 0.174; P = 0.168). CONCLUSIONS: The overall results appear to support that serum analysis is effective method for evaluating the presence of SS-A and SS-B autoantibodies.",
author = "Hammi, {Ann Rose} and Al-Hashimi, {Ibtisam H.} and Nunn, {Martha E.} and Michele Zipp",
year = "2005",
month = "4",
doi = "10.1111/j.1600-0714.2004.00301.x",
language = "English",
volume = "34",
pages = "198--203",
journal = "Journal of Oral Pathology and Medicine",
issn = "0904-2512",
publisher = "Wiley-Blackwell",
number = "4",

}

TY - JOUR

T1 - Assessment of SS-A SS-B in parotid saliva of patients with Sjögren's syndrome

AU - Hammi, Ann Rose

AU - Al-Hashimi, Ibtisam H.

AU - Nunn, Martha E.

AU - Zipp, Michele

PY - 2005/4

Y1 - 2005/4

N2 - BACKGROUND: The purpose of this study was to compare the sensitivity of parotid saliva to that of serum in detecting anti-SSA/Ro and anti-SSB/La autoantibodies in patients with Sjögren's syndrome. METHODS: Forty patients and 20 controls participated in the study; all patients met the 1993 European Community criteria for the diagnosis of Sjögren's syndrome. Healthy controls were age- and sex-matched individuals with no signs or symptoms of Sjögren's syndrome. Serum and saliva samples were evaluated using AffiniTech SSA/ Ro and SSB/La antibodies kits (AffiniTech, Ltd. Bentonville, AR, USA). The results were also compared with serological status of SS-A and SS-B as reported by an independent clinical laboratory. RESULTS: Serum was significantly more sensitive than saliva in detecting SSA/Ro and SSB/La antibodies (P = 0.001). There was high agreement between the results with the AffiniTech kits and the independent laboratory (kappa = 0.80; P <0.001). However, there was poor agreement between saliva and serum results (kappa = 0.174; P = 0.168). CONCLUSIONS: The overall results appear to support that serum analysis is effective method for evaluating the presence of SS-A and SS-B autoantibodies.

AB - BACKGROUND: The purpose of this study was to compare the sensitivity of parotid saliva to that of serum in detecting anti-SSA/Ro and anti-SSB/La autoantibodies in patients with Sjögren's syndrome. METHODS: Forty patients and 20 controls participated in the study; all patients met the 1993 European Community criteria for the diagnosis of Sjögren's syndrome. Healthy controls were age- and sex-matched individuals with no signs or symptoms of Sjögren's syndrome. Serum and saliva samples were evaluated using AffiniTech SSA/ Ro and SSB/La antibodies kits (AffiniTech, Ltd. Bentonville, AR, USA). The results were also compared with serological status of SS-A and SS-B as reported by an independent clinical laboratory. RESULTS: Serum was significantly more sensitive than saliva in detecting SSA/Ro and SSB/La antibodies (P = 0.001). There was high agreement between the results with the AffiniTech kits and the independent laboratory (kappa = 0.80; P <0.001). However, there was poor agreement between saliva and serum results (kappa = 0.174; P = 0.168). CONCLUSIONS: The overall results appear to support that serum analysis is effective method for evaluating the presence of SS-A and SS-B autoantibodies.

UR - http://www.scopus.com/inward/record.url?scp=15944407208&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=15944407208&partnerID=8YFLogxK

U2 - 10.1111/j.1600-0714.2004.00301.x

DO - 10.1111/j.1600-0714.2004.00301.x

M3 - Article

VL - 34

SP - 198

EP - 203

JO - Journal of Oral Pathology and Medicine

JF - Journal of Oral Pathology and Medicine

SN - 0904-2512

IS - 4

ER -